Intradermal injection Market Size and Scope 2031
The Intradermal Injection market size is projected to reach US$ 10.36 billion by 2031 from US$ 4.37 billion in 2023. The market is expected to register a CAGR of 11.50% during 2023–2031. The rising strategic developments by manufacturers are likely to remain key trends in the market.
Intradermal Injection Market Analysis
An intradermal (ID) injection is a superficial injection of a substance into the dermis layer of the skin. Certain substances administered via an intradermal (ID) route can result in faster systemic uptake compared with subcutaneous injections. This can lead to a robust immune response for vaccinations, immunology, and novel cancer treatments, as well as faster drug uptake. Additionally, since the administration is nearer to the skin surface, the body's reaction to substances is more easily visible. The mounting prevalence of respiratory diseases and allergies and the increasing adoption of intradermal therapies in aesthetics boost the demand for Intradermal Injections.
Intradermal Injection Market Overview
As Highlighted by the Aesthetic Plastic Surgery National Databank, in 2020, over 7 million aesthetic procedures were performed in the US, among which the toxins and fillers, were leading with about 3.9 million procedures. Intradermal injections are mainly used to deliver various neurotoxins related to anti-aging treatments. The rising number of aesthetic procedures involving intradermal therapies is increasing the demand for intradermal injections. Additionally, expanding the application of intradermal injections in dermatology for the treatment of skin and hair diseases is likely to offer growth opportunities in the intradermal injection market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Intradermal Injection Market: Strategic Insights
Market Size Value in US$ 3,513.26 Million in 2021 Market Size Value by US$ 7,415.70 Million by 2028 Growth rate CAGR of 11.3% from 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Intradermal Injection Market: Strategic Insights
| Market Size Value in | US$ 3,513.26 Million in 2021 |
| Market Size Value by | US$ 7,415.70 Million by 2028 |
| Growth rate | CAGR of 11.3% from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Intradermal Injection Market Drivers and Opportunities
Mounting Number of Respiratory Infections to Favor Market
According to a factsheet released by WHO in November 2023, around 10.6 million individuals contracted tuberculosis (TB) globally in 2022. Many respiratory diseases, including TB, influenza, and COVID-19, can be diagnosed by tuberculin skin test, which involves intradermal injection. The increasing prevalence of these diseases has led to an increase in the development of intradermal injections for treatment and diagnosis. For instance, in 2020, the FDA approved Fluzone, an intradermal vaccine of influenza developed by Sanofi. The injection is rapidly overtaking the influenza vaccine market and replacing the congenital treatments for these diseases. In addition, Pfizer received approval for its intradermal COVID-19 vaccine named Comirnaty for people above 16 years of age. Such developments by the market players are boosting the global Intradermal Injection market.
Expanding Applications in Dermatology Brings Growth Opportunities
Intradermal therapy, also called mesotherapy, involves a series of micro-injections of active ingredients into the superficial layer of the skin. While it has various clinical applications, it can be instrumental in dermatology for treating many patients. Various studies are being conducted to assess the efficacy and benefits of intradermal injections in treating dermatological conditions. For instance, in an article published in the Journal of Plastic & Reconstructive Surgery in April 2024, a study was carried out to investigate the impact of mechanical factors (syringe and needle size, length, and skin booster viscosity) on the force needed for intradermal injection in porcine skin. The study concluded that the administration of skin boosters via intradermal injections with smaller syringe diameters under optimal conditions maximizes rejuvenating outcomes. These ongoing studies are anticipated to help in the development of potential intradermal treatments in dermatology, offering lucrative growth opportunities in the intradermal injection market.
Intradermal Injection Market Report Segmentation Analysis
Key segments that contributed to the derivation of the intradermal injection market analysis are method, application, and end user.
- The is segmented based on the method into normal-sized needles, short needles, and needles without needles. The normal-sized needles segment held the largest market share in 2023.
- The intradermal injection market is segmented based on application into tuberculin skin tests, allergy tests, local aesthetics, and others. The tuberculin skin test segment held the largest share of the market in 2023.
- By end user, the market is segmented into hospitals, diagnostic laboratories, academics, research institutes, and others. The hospitals segment held the largest share of the market in 2023.
Intradermal Injection Market Share Analysis by Geography
The geographic scope of the Intradermal Injection market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. Asia Pacific is estimated to grow with the highest CAGR in the coming years.
The Intradermal Injection market in North America is analyzed based on the three major countries: the US, Canada, and Mexico. The US is projected to have the largest share of the North American intradermal Injection market in 2023.
TB is one of the major bacterial infections in well-matured countries, including the US. According to the statistics published by the Centres of Disease Control and Prevention (CDC) in 2024, about 13 million individuals are living in the US with latent TB, while in 2022, 8,331 cases of TB were reported in the US, with a rate of 2.5 cases per 100,000 people. As the tuberculin skin test is the main test for the disease diagnosis, the demand for intradermal injections is high, which is increasing the market size of this segment.
Furthermore, the increasing adoption of technological advancements and rising R&D activities are projected to accelerate the growth of the intradermal injections market.
Intradermal Injection Market Report Scope
Intradermal Injection Market News and Recent Developments
The Intradermal Injection market is evaluated by gathering qualitative and quantitative data from primary and secondary research, which includes essential corporate publications, association data, and databases. A few of the developments in the Intradermal Injection market are listed below:
- NanoPass Technologies and Aesthetic Management Partners entered into an agreement to initiate the commercialization of NanoPass’s MicronJet 600 intradermal delivery device in the US. (Source: NanoPass Technologies, Press Release, November 2021).
- PharmaJet and Zydus Cadila received the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D, the world’s first Plasmid DNA Vaccine for COVID-19. The vaccine, ZyCoV-D, is solely administered utilizing the PharmaJet Tropis Needle-free Injection System. (Source: PharmaJet, Press Release, August 2021).
Intradermal Injection Market Report Coverage and Deliverables
The “Intradermal Injection Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Intradermal injection market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Intradermal injection market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Intradermal injection market analysis covering key market trends, global and regional framework, significant players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the intradermal injection market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Method,, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
North America dominated the Intradermal Injection market in 2023.
Factors including increasing prevalence of respiratory diseases and use of intradermal injection in aesthetics are the driving factors for the Intradermal Injection market growth.
The rising strategic developments by manufacturers are future trends in the market.
BD, Terumo Corporation, NanoPass, Pharmajet, Idevax, Eunsung Global, West Pharmaceutical Services, Inc., Crossject, Cardinal Health Inc, Hindustan Syringes and Medical Devices Ltd are some leading players operating in the intradermal injection market.
The Intradermal Injection market is estimated to reach US$ 10.36 billion by 2031.
The intradermal injection market is anticipated to grow at a CAGR of 11.50% from 2023 to 2031.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For